Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report) shares hit a new 52-week high during mid-day trading on Thursday. The company traded as high as $26.66 and last traded at $26.66, with a volume of 129 shares traded. The stock had previously closed at $24.80.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on WILYY shares. Sanford C. Bernstein lowered shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. UBS Group downgraded Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Morgan Stanley raised shares of Demant A/S from an “equal weight” rating to an “overweight” rating in a report on Tuesday, June 23rd. Finally, Zacks Research downgraded shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Research Report on WILYY
Demant A/S Price Performance
The firm’s 50-day moving average price is $23.21 and its 200-day moving average price is $20.16.
About Demant A/S
Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and other communication needs. The company serves consumers and hearing care professionals through activities spanning hearing aids, diagnostic equipment, hearing care services and specialized communications technology.
Its portfolio includes hearing aids and related software, audiological diagnostic instruments, and technologies used by hearing care professionals to assess and manage hearing conditions.
See Also
- Five stocks we like better than Demant A/S
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
